ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking

[1]  G. El Fakhri,et al.  Synthesis and Characterization of [18F]JNJ-46356479 as the First 18F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2 , 2021, Molecular Imaging and Biology.

[2]  G. Koob Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development , 2020, Pharmacological Reviews.

[3]  O. George,et al.  Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats , 2020, Psychopharmacology.

[4]  G. Koob Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement , 2020, Biological Psychiatry.

[5]  A. Matzeu,et al.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats , 2019, Neuropharmacology.

[6]  Zhiqiang Liu,et al.  Downregulation of mGluR2/3 receptors during morphine withdrawal in rats impairs mGluR2/3- and NMDA receptor-dependent long-term depression in the nucleus accumbens , 2019, Neuroscience Letters.

[7]  Z. Xi,et al.  Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats , 2018, Neuropsychopharmacology.

[8]  J. Schroeder,et al.  Molecular Adaptations in the Rat Dorsal Striatum and Hippocampus Following Abstinence-Induced Incubation of Drug Seeking After Escalated Oxycodone Self-Administration , 2018, Molecular Neurobiology.

[9]  K. Janda,et al.  Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions , 2017, Neuropharmacology.

[10]  P. Schweitzer,et al.  Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence , 2017, Neuropsychopharmacology.

[11]  F. Weiss,et al.  Perseveration of craving: effects of stimuli conditioned to drugs of abuse versus conventional reinforcers differing in demand , 2017, Addiction biology.

[12]  María Lourdes Linares,et al.  Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM). , 2016, Journal of medicinal chemistry.

[13]  A. Cross,et al.  The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats , 2016, Neuropsychopharmacology.

[14]  A. Cross,et al.  Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats , 2016, Psychopharmacology.

[15]  Y. Shaham,et al.  The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys , 2015, Biological Psychiatry.

[16]  G. Schoenbaum,et al.  Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model , 2015, Biological Psychiatry.

[17]  A. Haghparast,et al.  Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens , 2015, Pharmacology Biochemistry and Behavior.

[18]  P. Kalivas,et al.  Synaptic Glutamate Spillover Due to Impaired Glutamate Uptake Mediates Heroin Relapse , 2014, The Journal of Neuroscience.

[19]  R. Spanagel,et al.  Rescue of Infralimbic mGluR2 Deficit Restores Control Over Drug-Seeking Behavior in Alcohol Dependence , 2013, The Journal of Neuroscience.

[20]  Nirmal Singh,et al.  Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets. , 2013, CNS & neurological disorders drug targets.

[21]  Joseph P. Schacht,et al.  Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta‐analysis and systematic review , 2013, Addiction biology.

[22]  Zhiqiang Liu,et al.  Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal , 2012, Journal of neuroscience research.

[23]  J. Widholm,et al.  Alcohol‐seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate‐oxidase‐coated biosensors , 2011, Addiction biology.

[24]  P. Kalivas,et al.  Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction. , 2010, European journal of pharmacology.

[25]  D. Sheffler,et al.  The mGluR2 Positive Allosteric Modulator BINA Decreases Cocaine Self-Administration and Cue-Induced Cocaine-Seeking and Counteracts Cocaine-Induced Enhancement of Brain Reward Function in Rats , 2010, Neuropsychopharmacology.

[26]  R. LaLumiere,et al.  Glutamate transmission in addiction , 2009, Neuropharmacology.

[27]  P. Kalivas The glutamate homeostasis hypothesis of addiction , 2009, Nature Reviews Neuroscience.

[28]  Xiao-Hui Xiang,et al.  The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction , 2009, Neuroscience & Biobehavioral Reviews.

[29]  F. Weiss,et al.  Dissociation of the Effects of MTEP [3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on Conditioned Reinstatement and Reinforcement: Comparison between Cocaine and a Conventional Reinforcer , 2009, Journal of Pharmacology and Experimental Therapeutics.

[30]  P. Phillips,et al.  Phasic dopamine release in appetitive behaviors and drug addiction. , 2009, Current drug abuse reviews.

[31]  M. Liechti,et al.  Metabotropic Glutamate 2/3 Receptors in the Ventral Tegmental Area and the Nucleus Accumbens Shell Are Involved in Behaviors Relating to Nicotine Dependence , 2007, The Journal of Neuroscience.

[32]  F. Kobarfard,et al.  Sex differences and role of gonadal hormones on glutamate level in the nucleus accumbens in morphine tolerant rats: a microdialysis study. , 2007, European journal of pharmacology.

[33]  N. Volkow,et al.  The neural basis of addiction: a pathology of motivation and choice. , 2005, The American journal of psychiatry.

[34]  J. Seamans,et al.  Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking , 2005, The Journal of Neuroscience.

[35]  Chunfu Wu,et al.  Morphine decreases extracellular levels of glutamate in the anterior cingulate cortex: an in vivo microdialysis study in freely moving rats , 2005, Brain Research.

[36]  S. Nakanishi,et al.  Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  N. Volkow,et al.  Unmanageable Motivation in Addiction: A Pathology in Prefrontal-Accumbens Glutamate Transmission , 2005, Neuron.

[38]  Gary Aston-Jones,et al.  Brain substrates for increased drug seeking during protracted withdrawal , 2004, Neuropharmacology.

[39]  G. Barr,et al.  The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats , 2004, International Journal of Developmental Neuroscience.

[40]  F. Weiss,et al.  Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer , 2004, The Journal of Neuroscience.

[41]  P. Kenny,et al.  The ups and downs of addiction: role of metabotropic glutamate receptors. , 2004, Trends in pharmacological sciences.

[42]  J. Fiez,et al.  Prefrontal responses to drug cues: a neurocognitive analysis , 2004, Nature Neuroscience.

[43]  P. Kalivas,et al.  Glutamate systems in cocaine addiction. , 2004, Current opinion in pharmacology.

[44]  J. Sepúlveda,et al.  Neurochemical changes of the extracellular concentrations of glutamate and aspartate in the nucleus accumbens of rats after chronic administration of morphine. , 2004, European journal of pharmacology.

[45]  J. Stewart,et al.  A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats , 2003, Psychopharmacology.

[46]  P. Kalivas,et al.  Prefrontal Glutamate Release into the Core of the Nucleus Accumbens Mediates Cocaine-Induced Reinstatement of Drug-Seeking Behavior , 2003, The Journal of Neuroscience.

[47]  David Robbe,et al.  Metabotropic glutamate receptor 2/3‐dependent long‐term depression in the nucleus accumbens is blocked in morphine withdrawn mice , 2002, The European journal of neuroscience.

[48]  Z. Bashir,et al.  Cooperation between mglu receptors: a depressing mechanism? , 2002, Trends in Neurosciences.

[49]  J. Pin,et al.  The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. , 2002, Current drug targets. CNS and neurological disorders.

[50]  K. Berridge,et al.  The Neuroscience of Natural Rewards: Relevance to Addictive Drugs , 2002, The Journal of Neuroscience.

[51]  P. Kalivas,et al.  The Circuitry Mediating Cocaine-Induced Reinstatement of Drug-Seeking Behavior , 2001, The Journal of Neuroscience.

[52]  B. Everitt,et al.  Dissociable Effects of Antagonism of NMDA and AMPA/KA Receptors in the Nucleus Accumbens Core and Shell on Cocaine-seeking Behavior , 2001, Neuropsychopharmacology.

[53]  T L Faber,et al.  Neural activity related to drug craving in cocaine addiction. , 2001, Archives of general psychiatry.

[54]  T. Tzschentke Pharmacology and behavioral pharmacology of the mesocortical dopamine system , 2001, Progress in Neurobiology.

[55]  D. Schoepp,et al.  Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.

[56]  P. Kalivas,et al.  Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction , 2000, The Journal of Neuroscience.

[57]  P. Kalivas,et al.  A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior , 1999, Neuroscience.

[58]  C. Heyser,et al.  Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence. , 1999, Behavioural pharmacology.

[59]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[60]  K. A. Haberny,et al.  Interactive effects of MK-801 and morphine on EEG, EEG power spectra and behavior in rats: I. Morphine tolerance development. , 1994, European journal of pharmacology.

[61]  S. B. Caine,et al.  Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. , 1993, Science.

[62]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[63]  H. Bradford,et al.  Suppression of evoked and spontaneous release of neurotransmitters in vivo by morphine. , 1980, Biochemical pharmacology.

[64]  W. Zieglgänsberger,et al.  A DEMONSTRATION OF NALOXONE‐PRECIPITATED OPIATE WITHDRAWAL ON SINGLE NEURONES IN THE MORPHINE‐TOLERANT/DEPENDENT RAT BRAIN , 1980, British journal of pharmacology.

[65]  H. Loh,et al.  Quantitative aspects of precipitated abstinence in morphine-dependent rats. , 1973, The Journal of pharmacology and experimental therapeutics.

[66]  G. Koob,et al.  Compulsive-Like Responding for Opioid Analgesics in Rats with Extended Access , 2015, Neuropsychopharmacology.

[67]  M. Olive,et al.  Glutamatergic substrates of drug addiction and alcoholism. , 2008, Biochemical pharmacology.

[68]  P. Kalivas,et al.  Drug Addiction as a Pathology of Staged Neuroplasticity , 2008, Neuropsychopharmacology.

[69]  W. Zieglgänsberger,et al.  Supersensitivity of cortical neurones of the rat to acetylcholine and L-glutamate following chronic morphine treatment , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[70]  G. Siggins,et al.  Chronic morphine treatment selectively augments metabotropic glutamate receptor-induced inhibition of N-methyl-D-aspartate receptor-mediated neurotransmission in nucleus accumbens. , 1999, The Journal of pharmacology and experimental therapeutics.